Seeing Is Believing
KALV is currently covered by 6 analysts with an average price target of $29.66. This is a potential upside of $17.78 (149.66%) from yesterday's end of day stock price of $11.88.
Kalvista Pharmaceuticals's activity chart (see below) currently has 24 price targets and 32 ratings on display. The stock rating distribution of KALV is 100% BUY.
Analysts average stock forecasts to be materialized ratio is 55.83% with an average time for these price targets to be met of 362.25 days.
Highest price target for KALV is $35, Lowest price target is $20, average price target is $29.66.
Most recent stock forecast was given by SERGE BELANGER from NEEDHAM on 11-Mar-2024. First documented stock forecast 21-Sep-2018.
Currently out of the existing stock ratings of KALV, 16 are a BUY (100%).
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
35
$23.96 (217.03%)
35
1 months 7 days ago
3/10 (30%)
$21.9 (167.18%)
378
Buy
24
$12.96 (117.39%)
16
2 months 4 days ago
5/6 (83.33%)
$9.6 (66.67%)
287
Buy
20
$8.96 (81.16%)
32
7 months 27 days ago
2/3 (66.67%)
$9 (81.82%)
706
Buy
26
$14.96 (135.51%)
30
9 months 8 days ago
1/2 (50%)
$15.53 (148.33%)
135
Buy
20
$8.96 (81.16%)
1 years 2 months 15 days ago
0/2 (0%)
$12.13 (154.13%)
What is KALV (Kalvista Pharmaceuticals) average time for price targets to be met?
Which analyst has the current highest performing score on KALV (Kalvista Pharmaceuticals) with a proven track record?
Which analyst has the current lower performing score on KALV (Kalvista Pharmaceuticals) with a proven track record?
Which analyst has the most public recommendations on KALV (Kalvista Pharmaceuticals)?
Which analyst is the currently most bullish on KALV (Kalvista Pharmaceuticals)?
Which analyst is the currently most reserved on KALV (Kalvista Pharmaceuticals)?